A detailed history of Lido Advisors, LLC transactions in Global X Fds Genomics & Biotec stock. As of the latest transaction made, Lido Advisors, LLC holds 280,572 shares of GNOM stock, worth $2.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
280,572
Previous 299,812 6.42%
Holding current value
$2.9 Million
Previous $3.47 Million 7.88%
% of portfolio
0.02%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$10.75 - $12.29 $206,830 - $236,459
-19,240 Reduced 6.42%
280,572 $3.19 Million
Q4 2023

Feb 14, 2024

SELL
$8.77 - $11.77 $486,147 - $652,446
-55,433 Reduced 15.6%
299,812 $3.47 Million
Q3 2023

Nov 14, 2023

BUY
$10.07 - $12.5 $259,715 - $322,387
25,791 Added 7.83%
355,245 $3.61 Million
Q2 2023

Aug 09, 2023

BUY
$11.99 - $13.07 $65,765 - $71,688
5,485 Added 1.69%
329,454 $3.99 Million
Q1 2023

May 15, 2023

BUY
$11.73 - $14.18 $22,122 - $26,743
1,886 Added 0.59%
323,969 $3.99 Million
Q4 2022

Feb 14, 2023

BUY
$12.11 - $13.81 $3.9 Million - $4.45 Million
322,083 New
322,083 $4.07 Million

Others Institutions Holding GNOM

About GLOBAL X FDS GENOMICS & BIOTEC


  • Ticker GNOM
  • Sector ETFs
  • Industry ETFs
More about GNOM
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.